1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Service Type Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Service Type Market, by Service Type
8.1.1. Process Development & Optimization
8.1.1.1. Market Revenue and Forecast
8.1.2. Clinical-Scale Manufacturing
8.1.2.1. Market Revenue and Forecast
8.1.3. Commercial GMP Manufacturing
8.1.3.1. Market Revenue and Forecast
8.1.4. Downstream Purification & Fill-Finish
8.1.4.1. Market Revenue and Forecast
8.1.5. Analytical & QC Services
8.1.5.1. Market Revenue and Forecast
9.1. Service Type Market, by Scale/Capacity
9.1.1. Lab/Pilot Scale(<200 L)
9.1.1.1. Market Revenue and Forecast
9.1.2. Clinical Scale(200–2,000 L)
9.1.2.1. Market Revenue and Forecast
9.1.3. Large-Scale Commercial(>2,000 L)
9.1.3.1. Market Revenue and Forecast
10.1. Service Type Market, by Organism/Host System
10.1.1. Microbial (E. coli, Yeast)
10.1.1.1. Market Revenue and Forecast
10.1.2. Yeast
10.1.2.1. Market Revenue and Forecast
10.1.3. Mammalian Cells (CHO, HEK)
10.1.3.1. Market Revenue and Forecast
10.1.4. Viral Vector/Cell Therapy Platforms
10.1.4.1. Market Revenue and Forecast
11.1. Service Type Market, by Product Type
11.1.1. Monoclonal Antibodies(mAbs)
11.1.1.1. Market Revenue and Forecast
11.1.2. Recombinant Proteins & Enzymes
11.1.2.1. Market Revenue and Forecast
11.1.3. Vaccines
11.1.3.1. Market Revenue and Forecast
11.1.4. Cell & Gene Therapy(AAV, Lentivirus)
11.1.4.1. Market Revenue and Forecast
11.1.5. Biosimilars
11.1.5.1. Market Revenue and Forecast
12.1. Service Type Market, by End-User
12.1.1. Large Pharmaceutical Companies
12.1.1.1. Market Revenue and Forecast
12.1.2. Biotechnology Companies/Biotechs
12.1.2.1. Market Revenue and Forecast
12.1.3. Vaccine Developers
12.1.3.1. Market Revenue and Forecast
12.1.4. Academic Spinouts/SMEs
12.1.4.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Service Type
13.1.2. Market Revenue and Forecast, by Scale/Capacity
13.1.3. Market Revenue and Forecast, by Organism/Host System
13.1.4. Market Revenue and Forecast, by Product Type
13.1.5. Market Revenue and Forecast, by End-User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Service Type
13.1.6.2. Market Revenue and Forecast, by Scale/Capacity
13.1.6.3. Market Revenue and Forecast, by Organism/Host System
13.1.6.4. Market Revenue and Forecast, by Product Type
13.1.6.5. Market Revenue and Forecast, by End-User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Service Type
13.1.7.2. Market Revenue and Forecast, by Scale/Capacity
13.1.7.3. Market Revenue and Forecast, by Organism/Host System
13.1.7.4. Market Revenue and Forecast, by Product Type
13.1.7.5. Market Revenue and Forecast, by End-User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Service Type
13.2.2. Market Revenue and Forecast, by Scale/Capacity
13.2.3. Market Revenue and Forecast, by Organism/Host System
13.2.4. Market Revenue and Forecast, by Product Type
13.2.5. Market Revenue and Forecast, by End-User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Service Type
13.2.6.2. Market Revenue and Forecast, by Scale/Capacity
13.2.6.3. Market Revenue and Forecast, by Organism/Host System
13.2.7. Market Revenue and Forecast, by Product Type
13.2.8. Market Revenue and Forecast, by End-User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Service Type
13.2.9.2. Market Revenue and Forecast, by Scale/Capacity
13.2.9.3. Market Revenue and Forecast, by Organism/Host System
13.2.10. Market Revenue and Forecast, by Product Type
13.2.11. Market Revenue and Forecast, by End-User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Service Type
13.2.12.2. Market Revenue and Forecast, by Scale/Capacity
13.2.12.3. Market Revenue and Forecast, by Organism/Host System
13.2.12.4. Market Revenue and Forecast, by Product Type
13.2.13. Market Revenue and Forecast, by End-User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Service Type
13.2.14.2. Market Revenue and Forecast, by Scale/Capacity
13.2.14.3. Market Revenue and Forecast, by Organism/Host System
13.2.14.4. Market Revenue and Forecast, by Product Type
13.2.15. Market Revenue and Forecast, by End-User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Service Type
13.3.2. Market Revenue and Forecast, by Scale/Capacity
13.3.3. Market Revenue and Forecast, by Organism/Host System
13.3.4. Market Revenue and Forecast, by Product Type
13.3.5. Market Revenue and Forecast, by End-User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Service Type
13.3.6.2. Market Revenue and Forecast, by Scale/Capacity
13.3.6.3. Market Revenue and Forecast, by Organism/Host System
13.3.6.4. Market Revenue and Forecast, by Product Type
13.3.7. Market Revenue and Forecast, by End-User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Service Type
13.3.8.2. Market Revenue and Forecast, by Scale/Capacity
13.3.8.3. Market Revenue and Forecast, by Organism/Host System
13.3.8.4. Market Revenue and Forecast, by Product Type
13.3.9. Market Revenue and Forecast, by End-User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Service Type
13.3.10.2. Market Revenue and Forecast, by Scale/Capacity
13.3.10.3. Market Revenue and Forecast, by Organism/Host System
13.3.10.4. Market Revenue and Forecast, by Product Type
13.3.10.5. Market Revenue and Forecast, by End-User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Service Type
13.3.11.2. Market Revenue and Forecast, by Scale/Capacity
13.3.11.3. Market Revenue and Forecast, by Organism/Host System
13.3.11.4. Market Revenue and Forecast, by Product Type
13.3.11.5. Market Revenue and Forecast, by End-User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Service Type
13.4.2. Market Revenue and Forecast, by Scale/Capacity
13.4.3. Market Revenue and Forecast, by Organism/Host System
13.4.4. Market Revenue and Forecast, by Product Type
13.4.5. Market Revenue and Forecast, by End-User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Service Type
13.4.6.2. Market Revenue and Forecast, by Scale/Capacity
13.4.6.3. Market Revenue and Forecast, by Organism/Host System
13.4.6.4. Market Revenue and Forecast, by Product Type
13.4.7. Market Revenue and Forecast, by End-User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Service Type
13.4.8.2. Market Revenue and Forecast, by Scale/Capacity
13.4.8.3. Market Revenue and Forecast, by Organism/Host System
13.4.8.4. Market Revenue and Forecast, by Product Type
13.4.9. Market Revenue and Forecast, by End-User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Service Type
13.4.10.2. Market Revenue and Forecast, by Scale/Capacity
13.4.10.3. Market Revenue and Forecast, by Organism/Host System
13.4.10.4. Market Revenue and Forecast, by Product Type
13.4.10.5. Market Revenue and Forecast, by End-User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Service Type
13.4.11.2. Market Revenue and Forecast, by Scale/Capacity
13.4.11.3. Market Revenue and Forecast, by Organism/Host System
13.4.11.4. Market Revenue and Forecast, by Product Type
13.4.11.5. Market Revenue and Forecast, by End-User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Service Type
13.5.2. Market Revenue and Forecast, by Scale/Capacity
13.5.3. Market Revenue and Forecast, by Organism/Host System
13.5.4. Market Revenue and Forecast, by Product Type
13.5.5. Market Revenue and Forecast, by End-User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Service Type
13.5.6.2. Market Revenue and Forecast, by Scale/Capacity
13.5.6.3. Market Revenue and Forecast, by Organism/Host System
13.5.6.4. Market Revenue and Forecast, by Product Type
13.5.7. Market Revenue and Forecast, by End-User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Service Type
13.5.8.2. Market Revenue and Forecast, by Scale/Capacity
13.5.8.3. Market Revenue and Forecast, by Organism/Host System
13.5.8.4. Market Revenue and Forecast, by Product Type
13.5.8.5. Market Revenue and Forecast, by End-User
14.1. Catalent, Inc
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Thermo Fisher Scientific
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. WuXi Biologics
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Samsung Biologics
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Boehringer Ingelheim
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Fujifilm Diosynth Biotechnologies
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Novasep
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. AGC Biologics
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Biocon Biologics
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Rentschler Biopharma SE
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
